國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁 到查詢結果 [ subject:"Stents (Surgery)" ]

切換: 標籤 | MARC模式 | ISBD

Coronary artery disease and the evol...

King, Martin W.

Coronary artery disease and the evolution of angioplasty devices

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Coronary artery disease and the evolution of angioplasty devicesby Martin W. King ... [et al.].
其他作者:	King, Martin W.
出版者:	Cham :Springer International Publishing :2020.
面頁冊數:	xiv, 66 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Coronary heart disease.
電子資源:	https://doi.org/10.1007/978-3-030-42443-5
ISBN:	9783030424435$q(electronic bk.)

Coronary artery disease and the evolution of angioplasty devices
Coronary artery disease and the evolution of angioplasty devices[electronic resource] /by Martin W. King ... [et al.]. - Cham :Springer International Publishing :2020. - xiv, 66 p. :ill., digital ;24 cm. - SpringerBriefs in materials,2192-1091. - SpringerBriefs in materials..

Chapter1. Epidemiology and Risk Factors -- Chapter2. Definitions and Basic Mechanism of Coronary Artery Disease (CAD) -- Chapter3. Coronary Microvascular Dysfunction (CMD) -- Chapter4. Diagnosis of Coronary Artery Disease -- Chapter5. Treatment of Coronary Artery Disease -- Chapter6. Evolution of Angioplasty.

09 billion by 2035.In this concise but authoritative book, the authors take the reader through the epidemiology, risk factors and the basic mechanism of coronary artery disease. In addition, they explain how coronary microvascular dysfunction can lead to angina, even after successful angioplasty following a heart attack. The methods for diagnosis and the options for treatment are explained, ending with a discussion of the evolution of coronary angioplasty from balloon catheters to novel, fully resorbable polymeric drug eluting stents. Enclosed is a list of currently available commercial devices, as well as a listing of experimental products under research and development, so that readers can appreciate the serious nature of this disease and have an understanding of how the medical device sector is attempting to address this major healthcare problem. Globally in 2010, ischemic heart disease was the cause of 13.3% of all deaths. In the US alone, the direct medical costs from coronary artery disease and stroke are currently estimated to be

ISBN: 9783030424435$q(electronic bk.)

Standard No.: 10.1007/978-3-030-42443-5doiSubjects--Topical Terms:

273803
Coronary heart disease.

LC Class. No.: RC685.C6

Dewey Class. No.: 616.123

Coronary artery disease and the evolution of angioplasty devices
LDR:02430nmm a2200349 a 4500 001 579462
003 DE-He213
005 20200923091431.0
006 m
007 cr
008 201229s2020
020 $a 9783030424435$q(electronic bk.)
020 $a 9783030424428$q(paper)
024 7 $a 10.1007/978-3-030-42443-5 $2 doi
035 $a 978-3-030-42443-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC685.C6
072 7 $a TGM $2 bicssc
072 7 $a TEC021000 $2 bisacsh
072 7 $a TGM $2 thema
072 7 $a TCB $2 thema
082 0 4 $a 616.123 $2 23
090 $a RC685.C6 $b C822 2020
245 0 0 $a Coronary artery disease and the evolution of angioplasty devices $h [electronic resource] / $c by Martin W. King ... [et al.].
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a xiv, 66 p. : $b ill., digital ; $c 24 cm.
490 1 $a SpringerBriefs in materials, $x 2192-1091
505 0 $a Chapter1. Epidemiology and Risk Factors -- Chapter2. Definitions and Basic Mechanism of Coronary Artery Disease (CAD) -- Chapter3. Coronary Microvascular Dysfunction (CMD) -- Chapter4. Diagnosis of Coronary Artery Disease -- Chapter5. Treatment of Coronary Artery Disease -- Chapter6. Evolution of Angioplasty.
520 $a In this concise but authoritative book, the authors take the reader through the epidemiology, risk factors and the basic mechanism of coronary artery disease. In addition, they explain how coronary microvascular dysfunction can lead to angina, even after successful angioplasty following a heart attack. The methods for diagnosis and the options for treatment are explained, ending with a discussion of the evolution of coronary angioplasty from balloon catheters to novel, fully resorbable polymeric drug eluting stents. Enclosed is a list of currently available commercial devices, as well as a listing of experimental products under research and development, so that readers can appreciate the serious nature of this disease and have an understanding of how the medical device sector is attempting to address this major healthcare problem. Globally in 2010, ischemic heart disease was the cause of 13.3% of all deaths. In the US alone, the direct medical costs from coronary artery disease and stroke are currently estimated to be $1 26 billion per year, and are expected to rise to $3 09 billion by 2035.
650 0 $a Coronary heart disease. $3 273803
650 0 $a Stents (Surgery) $3 357468
650 1 4 $a Biomaterials. $3 274415
650 2 4 $a Biomedical Engineering and Bioengineering. $3 826326
650 2 4 $a Biomedical Engineering/Biotechnology. $3 730838
650 2 4 $a Cardiology. $3 273804
650 2 4 $a Vascular Surgery. $3 273855
650 2 4 $a Cardiac Surgery. $3 275925
700 1 $a King, Martin W. $3 683602
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a SpringerBriefs in materials. $3 558608
856 4 0 $u https://doi.org/10.1007/978-3-030-42443-5
950 $a Chemistry and Materials Science (Springer-11644)